| Basics |
Pacific Biosciences of California, Inc.
Pacific Biosciences of California Inc is a biotechnology company. It is engaged in design, development, and manufacture of sequencing system to help scientists resolve genetically complex problems.
|
| IPO Date: |
October 27, 2010 |
| Sector: |
Healthcare |
| Industry: |
Medical Diagnostics and Research |
| Market Cap: |
$721.56M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.24 | 3.25%
|
| Avg Daily Range (30 D): |
$0.11 | 5.26%
|
| Avg Daily Range (90 D): |
$0.07 | 4.25%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
2.68M |
| Avg Daily Volume (30 D): |
9.6M |
| Avg Daily Volume (90 D): |
7.79M |
| Trade Size |
| Avg Trade Size (Sh.): |
197 |
| Avg Trade Size (Sh.) (30 D): |
464 |
| Avg Trade Size (Sh.) (90 D): |
490 |
| Institutional Trades |
| Total Inst.Trades: |
4,368 |
| Avg Inst. Trade: |
$2.17M |
| Avg Inst. Trade (30 D): |
$.82M |
| Avg Inst. Trade (90 D): |
$.87M |
| Avg Inst. Trade Volume: |
.23M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.34M |
| Avg Closing Trade (30 D): |
$.84M |
| Avg Closing Trade (90 D): |
$.97M |
| Avg Closing Volume: |
341.37K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-1.67
|
$-.13
|
$-.14
|
|
Diluted EPS
|
$-2.13
|
$-.13
|
$-.14
|
|
Revenue
|
$ 154.58M
|
$ 38.44M
|
$ 39.77M
|
|
Gross Profit
|
$ 39.27M
|
$ 15.9M
|
$ 14.68M
|
|
Net Income / Loss
|
$ -503.63M
|
$ -38M
|
$ -41.93M
|
|
Operating Income / Loss
|
$ -665.69M
|
$ -38.88M
|
$ -44.85M
|
|
Cost of Revenue
|
$ 115.31M
|
$ 22.54M
|
$ 25.08M
|
|
Net Cash Flow
|
$ -21.91M
|
$ 1.66M
|
$ -4.09M
|
|
PE Ratio
|
|
|
|
|
|
|
